A total of 283 patients were randomised and received at least one dose of study
medicine(s). The table below shows the gender and age of these patients.
Patients who received at least one dose of study medicine(s)
Vilanterol Fluticasone furoate and
vilanterol
142 patients 141 patients
Gender
Female 70 (49%) 71 (50%)
Male 72 (51%) 70 (50%)
Age - in years
Range 48 to 90 42 to 85
Average 66 64
For more detailed information about the patients included in this study, see the
scientific results summaries (links to those summaries are provided at the end of this
document).
Where was this study done?
Study sites were in five countries.
Number of patients who received at least one dose of
study medicine(s)
Canada 27
Germany 34
Netherlands 56
Spain 59
United States 107
0 20 40 60 80 100 120
Number of patients